Phase I and pharmacokinetic study of gemcitabine administered at fixed-dose rate, combined with docetaxel/melphalan/carboplatin, with autologous hematopoietic progenitor-cell support, in patients with advanced refractory tumors. (Q46939586)
Jump to navigation
Jump to search
scientific article published on 7 September 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I and pharmacokinetic study of gemcitabine administered at fixed-dose rate, combined with docetaxel/melphalan/carboplatin, with autologous hematopoietic progenitor-cell support, in patients with advanced refractory tumors. |
scientific article published on 7 September 2007 |
Statements
Phase I and pharmacokinetic study of gemcitabine administered at fixed-dose rate, combined with docetaxel/melphalan/carboplatin, with autologous hematopoietic progenitor-cell support, in patients with advanced refractory tumors (English)
Yago Nieto
José Rifón
Javier Pérez-Calvo
Ana Zafra
Laura Zufia
Antonio Viúdez
Santiago Viteri
José Manuel Aramendía
Marta Moreno
Onintza Sayar
Milagros Hernández